Nima J. Movahedi

In addition to representing life sciences, technology, financial services, aerospace, retail and entertainment companies on an ongoing basis, Mr. Movahedi’s representative transactions include advising the following companies:

Mergers & Acquisitions

• Offerpad in its pending US$3 billion merger with Supernova Partners Acquisition Corporation
• Owlet in its pending US$1.4 billion merger with Sandbridge Acquisition Corporation
• Latch in its pending US$1.6 billion merger with TS Innovation Acquisitions Corp.
• Talkspace in its pending US$1.6 billion merger with Hudson Executive Investment Corp.
• Ouster in its US$1.9 billion merger with Colonnade Acquisition Corp.
• GCM Grosvenor in its US$2 billion merger with CF Finance Acquisition Corp.
• Cryoport in its US$320 million acquisition of the cryobiological products business of Chart Industries
• Virgin Galactic in its US$1.5 billion merger with Social Capital Hedosophia Holdings
• The Committee of Independent Directors of T-Mobile US in its US$146 billion merger between T-Mobile US and Sprint
• Impact Biomedicines in its up to US$7 billion sale to Celgene
• PIMCO in its acquisition of Gurtin Municipal Bond Management
• ICU Medical in its US$900 million acquisition of the Hospira Infusion Systems business of Pfizer 
• Breathe Technologies in its sale to Hill-Rom for US$130 million
• Mission Lane in its acquisition of the credit cards business of LendUp
• Putney in its US$200 million sale to Dechra Pharmaceuticals 

VC / Emerging Companies

• Invus Opportunities in several equity and debt investments totaling over US$300 million
• Novo Ventures in several equity and debt investments totaling over US$50 million
• Evergent Technologies in its equity financing led by TZP Group
• Relievant Medsystems in its US$58 million equity financing led by Endeavour
• Indigo Ag in several rounds of financing totaling over US$150 million

Capital Markets

• Amgen in its US$3.2 billion investment in BeiGene
• Cryoport in its US$275 million private placement with Blackstone
• Switch in its US$610 million IPO 
• Redwood Trust in its offering of US$245 million in convertible senior notes 
• Jefferies in connection with the IPO of Aclaris Therapeutics